Alzheimer's Disease Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Adults aged 60 or older, both male and female.
- People who meet the National Institute of Aging and Alzheimer's Association (NIA-AA) criteria for Mild Cognitive Impairment (MCI) — a condition involving mild memory or thinking changes — and who have had a brain scan (amyloid PET) showing a positive result for amyloid deposits.
- People who are able to read and understand the consent forms for the trial and who have voluntarily agreed to take part by signing those forms.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have been diagnosed with dementia according to recognised medical diagnostic guidelines (DSM-5 or ICD-10).
- People currently receiving treatment for a malignant (cancerous) tumour — though people who have fully recovered from cancer for more than 5 years, or those with certain skin cancers (basal cell or squamous cell carcinoma) or prostate cancer, may still be considered at the trial doctor's discretion.
- People who cannot read or write, or who have had no formal education.
- People whom the trial investigator considers unsuitable for the study for any other reason.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +82-2-3779-1880
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Primary endpoints
amyloid PET scan
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.